Measuring and valuing outcomes

News
September 2015

OHE and University of Sheffield to Collaborate on Research to Re-model the UK Value Set (‘MVH’) for EQ-5D

News
August 2015

Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations

News
July 2015

OHE and Peking University of China to Collaborate on Research to Explore the Inconsistent Ordering of Levels of the EQ-5D-5L Value Set

News
July 2015

An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies

News
June 2015

Patient-reported outcomes measures (PROMs) in Health Economics – an Overview and Key Developments in the Field

News
May 2015

PriMHE Lecture: Relative Effectiveness and the Impact on Drug Development

News
May 2015

OHE’s Professor Nancy Devlin and Koonal Shah Join the EuroQol Research Foundation’s Valuation Working Group

News
April 2015

international Decision Support Initiative (iDSI): Mapping of Priority-setting in Health in 17 Low and Middle Income Countries Across Asia, Latin America and Africa

News
April 2015

OHE Publishes in the Journal of Comparative Effectiveness Research: Future Expectations of Evidence of Relative Effectiveness in Europe and Comparative Effectiveness in the USA in 2020

31-Mar-multi-indication-medicines-BLOG-template.-25-03-2015

News
March 2015

Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK

10-Mar-Chart-Elements-in-payer-assessment-of-value

News
March 2015

A Framework for Payer Assessment of the Value of New Technologies: A US Approach

News
January 2015

Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values

Latest Research & Publications

R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C

Establishing a Reasonable Price for an Orphan Drug

Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals

Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”

The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries

The UK Biotech Sector and Brexit: Past Performance and Future Prospects

New Methods for Analysing the Distribution of EQ-5D Observations

All Publications

Filter results by

Filter results by

OHE and University of Sheffield to Collaborate on Research to Re-model the UK Value Set (‘MVH’) for EQ-5D

Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations

OHE and Peking University of China to Collaborate on Research to Explore the Inconsistent Ordering of Levels of the EQ-5D-5L Value Set

An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies

Patient-reported outcomes measures (PROMs) in Health Economics – an Overview and Key Developments in the Field

PriMHE Lecture: Relative Effectiveness and the Impact on Drug Development

OHE’s Professor Nancy Devlin and Koonal Shah Join the EuroQol Research Foundation’s Valuation Working Group

international Decision Support Initiative (iDSI): Mapping of Priority-setting in Health in 17 Low and Middle Income Countries Across Asia, Latin America and Africa

OHE Publishes in the Journal of Comparative Effectiveness Research: Future Expectations of Evidence of Relative Effectiveness in Europe and Comparative Effectiveness in the USA in 2020

Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK

A Framework for Payer Assessment of the Value of New Technologies: A US Approach

Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values

Share on Mastodon